Carlos Erasun Lecuona MD, MSc
About Carlos Erasun Lecuona MD, MSc
Carlos Erasun Lecuona MD, MSc is the Director of Early Clinical Development in Hematology/Oncology & Cell Therapy at Bristol Myers Squibb. He has extensive experience in clinical research and medical advisory roles, with a strong focus on early drug development in hematology and oncology.
Current Role at Bristol Myers Squibb
Carlos Erasun Lecuona currently holds the position of Director, Early Clinical Development - Hematology/Oncology & Cell Therapy at Bristol Myers Squibb. His work focuses primarily on early drug development within these specialized medical fields. This role emphasizes the innovation and implementation of new treatments, aiming at advancing patient care and therapeutic outcomes.
Previous Experience at Institut Català d'Oncologia
Before joining Bristol Myers Squibb, Carlos worked at Institut Català d'Oncologia (ICO) where he was involved in the Phase 1 / Drug Development Program. As a Clinical Research Fellow and Head of the Neck Cancer Unit, he spent one year from 2021 to 2022 in Hospitalet de Llobregat, Cataluña, España. His role included exploring initial phases of clinical trials and contributing to advancements in oncology.
Medical Advisor and MSL Manager at Pierre Fabre Group
Carlos Erasun Lecuona served as both Medical Advisor and MSL Manager at Pierre Fabre Group. He spent three years as a Medical Advisor from 2019 to 2022 in Barcelona, and briefly as an MSL Manager from 2020 to 2021. His responsibilities likely included providing medical and scientific support, as well as liaising between the company's clinical development teams and healthcare professionals.
Education and Credentials
Carlos boasts a robust educational background in medical and business disciplines. He obtained his Bachelor's degree in Medical from the University of Navarra (2007-2012). He also earned a Master’s degree in Palliative Care from Universitat de Vic – Universitat Central de Catalunya (2015-2018). His education includes business expertise from thePowerMBA program and management training from the Krauthammer Start Program (2020-2021). These credentials equip him with a multidisciplinary approach to medical and clinical development.
Clinical Research Fellowships
He completed multiple fellowships and internships that solidified his expertise in Clinical Research. This includes a significant role in the Molecular Therapy Investigational Unit and Lung Cancer Unit at Vall d'Hebron Barcelona Hospital Campus (2018-2019), and an internship at University of California San Diego's Head and Neck Oncology Program's patient care team in 2018. These experiences underscore his dedication to advancing oncology research.